tradingkey.logo

Tempus AI Inc

TEM
查看详细走势图
61.840USD
-1.670-2.63%
交易中 美东报价延迟15分钟
11.00B总市值
亏损市盈率 TTM

Tempus AI Inc

61.840
-1.670-2.63%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.63%

5天

-9.54%

1月

+0.60%

6月

+6.09%

今年开始到现在

+4.72%

1年

+21.80%

查看详细走势图

TradingKey Tempus AI Inc股票评分

单位: USD 更新时间: 2026-01-29

操作建议

Tempus AI Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名72/393位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价87.42。中期看,股价处于下降通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Tempus AI Inc评分

相关信息

行业排名
72 / 393
全市场排名
176 / 4540
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Tempus AI Inc亮点

亮点风险
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
业绩高增长
公司营业收入稳步增长,连续3年增长116.24%
利润高增长
公司净利润处于行业前列,最新年度总收入693.40M美元
估值低估
公司最新PE估值-218.48,处于3年历史低位
机构减仓
最新机构持股89.83M股,环比减少1.59%
罗恩·巴伦持仓
明星投资者罗恩·巴伦持仓,最新持仓市值263.25K

分析师目标

根据 15 位分析师
买入
评级
87.419
目标均价
+30.85%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Tempus AI Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Tempus AI Inc简介

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
公司代码TEM
公司Tempus AI Inc
CEOLefkofsky (Eric P)
网址https://investors.tempus.com/
KeyAI